
|Articles|June 14, 2010
Berlin Poetry Bio
Richard M. Berlin, MD, is Senior Affiliate in Psychiatry at the University of Massachusetts Medical School. His second collection of poems, Secret Wounds, which won the 2010 John Ciardi Poetry Prize, is published by BkMk Press.
Advertisement
Richard M. Berlin, MD, is Senior Affiliate in Psychiatry at the University of Massachusetts Medical School. His second collection of poems, Secret Wounds, which won the 2010 John Ciardi Poetry Prize, is published by BkMk Press.
Email:
Listen to Dr Berlin's work come to life in his readings:
Advertisement
Related to this article

In first open-label phase 3 data from the ADEPT program, KarXT cut hallucination and delusion scores in Alzheimer disease psychosis, with no new safety signals.

2R,6R-HNK reproduces ketamine’s rapid antidepressant profile in rodents without dissociation or abuse signals, and is now in four phase 2 trials.

Explore how clinicians subtype depression using severity, stressors, suicidality, sleep, and anxiety patterns to sharpen diagnosis, guide treatment, and build trust.

Learn more about the randomized, double-blind phase 2b study of naturally derived psilocybin in MDD, and more.

In 2 pivotal phase 3 studies, all 5 readers hit sensitivity and specificity targets for florquinitau F 18 tau PET, including in patients with early symptomatic Alzheimer disease.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Ketamine for Treatment-Resistant Depression: Practical Clinical Considerations
2
sNDA Submitted: Caplyta for the Treatment of Bipolar Mania
3
Real-World Lecanemab Outcomes in Alzheimer Disease, Reported at 3 Years
4
Mixed Results From Phase 3 Data for AR1001 in Alzheimer Disease
5



